Finnish Bioindustries FIB nimittää Alexandra Pethin toiminnanjohtajaksi

19.4.2023

Organon ostaa Forendo Pharman - yrityskauppa lisää naisten terveyden uusiin hoitomuotoihin tähtääviä ehdokkaita.

11.11.2021

BioFinland Pitching Competition -kilpailun lopputilaisuuden videotallenne

4.10.2021

Biomarkkerien kaupallistamisen työkalut nyt saatavilla (osoitteessa biomarker.nu).

24.11.2020

AGTC Joins the My Retina Tracker® Program as a New Scientific Collaborator

7.10.2020

Commercializing IVD-Applicable Biomarkers: Best Practices and Pitfalls Handbook is now available

11.8.2020

#TogetherAgainstCOVID19 – EuropaBio Interview with Finnish Bioindustries

25.6.2020

Quest Diagnostics Acquires Blueprint Genetics to Broaden Access to Actionable Insights for Genetic and Rare Diseases

22.1.2020

Blueprint Genetics expands in North America by building a new CLIA/CAP NGS facility in Seattle

24.5.2019

DelSiTech Ltd Receives Significant Funding for Developing Long-Acting Injectables for contraceptives and HIV antivirals development by the Bill & Melinda Gates Foundation

21.5.2019

Helsinki Biobank and Fimmic Introduce a Unique One Access Service for Biomedical Research

26.10.2018

Life Science Mentors – Mentoring Service for Finnish Life Science Actors

11.4.2018

Faron Pharmaceuticals Admission to AIM and first day of dealings £10 million fundraise to progress Phase III clinical trial

17.11.2015

Faron Enters Agreement with Selexis SA to Progress Development of Novel Cancer Immunotherapy Clevegen

3.11.2015